Press release
Losartan Potassium Active Pharmaceutical Ingredient (API) Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities
Losartan Potassium Active Pharmaceutical Ingredient (API)
What Is the Projected Growth of the Losartan Potassium Active Pharmaceutical Ingredient (API) Market?
The market size of the losartan potassium active pharmaceutical ingredient (API) has seen impressive growth in the past few years. The prediction is that it will expand from $1.75 billion in 2024 to about $1.87 billion in 2025, showing a compound annual growth rate (CAGR) of about 7.0%. This growth occurred due to several factors such as higher usage of antihypertensive drugs, escalating cases of disorders related to lifestyle, increasing knowledge of cardiovascular health, growing global expenditure on healthcare, and a surged demand for economical generic medications.
Expectations are high for a significant expansion in the losartan potassium active pharmaceutical ingredient (API) market in the upcoming years. By 2029, it is estimated to surge to $2.44 billion, with a CAGR of 6.9%. Factors likely to fuel this rise during the forecast period include a growing set of patients with chronic diseases, an increased emphasis on preventive care for cardiovascular health, the spread of healthcare services in developing markets, advancements in the technology around drug formulation, and the government's encouragements towards promoting generic drugs. Key trends during the forecast period encompass enhancements in manufacturing procedures, improvements in drug delivery systems, the emergence of pediatric-accommodating formulations, innovations in packaging for increased longevity, and the advent of combination therapies involving losartan.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/customise?id=24285&type=smp
What Are the Different Losartan Potassium Active Pharmaceutical Ingredient (API) Market Segments?
The losartan potassium active pharmaceutical ingredient (API) market covered in this report is segmented -
1) By Product Type: Tablet, Capsule, Other Product Types
2) By Production Method: Synthetic Route, Biotechnological Process, Continuous Flow Production
3) By Distribution Channel: Online Pharmacies, Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels
4) By Application: Hypertension, Heart Failure, Chronic Kidney Diseases, Other Applications
5) By End-User: Hospitals, Clinics, Home Care Settings, Pharmaceutical Companies
Subsegments:
1) By Tablet: Immediate-Release Tablets, Extended-Release Tablets, Film-Coated Tablets, Orally Disintegrating Tablets
2) By Capsule: Hard Gelatin Capsules, Soft Gelatin Capsules, Modified-Release Capsules
3) By Other Product Types: Injectable Formulations, Bulk Active Pharmaceutical Ingredient (API) Powder, Granules For Suspension, Pre-Formulated Intermediates
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24285&type=smp
What Are the Primary Drivers Shaping the Losartan Potassium Active Pharmaceutical Ingredient (API) Market?
The escalating incidence of high blood pressure is anticipated to spur the expansion of the losartan potassium active pharmaceutical ingredient (API) market in the future. Chronic high blood pressure, or hypertension, enhances the risk of conditions like heart disease, stroke, and other major health issues. The increase in hypertension cases is correlated with consumption of high-salt and processed food diets that cause fluid buildup and augmented cardiac stress. Losartan potassium combats hypertension by inhibiting the angiotensin II hormone responsible for constricting blood vessels. It aids in dilating and relaxing the vessels, reducing blood pressure and alleviating strain on the heart. For instance, the American Heart Association, a nonprofit based in the United States, reported in January 2024, that there were 131,454 deaths mainly associated with high blood pressure in 2022, a rise from 124,508 deaths in 2021. Therefore, the escalating incidence of hypertension is stimulating the expansion of the losartan potassium active pharmaceutical (API) market.
Which Companies Are Leading in the Losartan Potassium Active Pharmaceutical Ingredient (API) Market?
Major companies operating in the losartan potassium active pharmaceutical ingredient (API) market are Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma Ltd, Dr. Reddy's Laboratories, Cadila Pharmaceuticals Ltd, Lupin Ltd, Zydus Lifesciences Ltd, Alkem Laboratories Ltd, IPCA Laboratories Ltd, Alembic Pharmaceuticals Ltd, Granules India Limited, Vasudha Pharma Chem Ltd, IOL Chemicals and Pharmaceuticals Limited, Unichem Laboratories Ltd, Global Pharma Tek, Hetero Drugs Ltd, Manus Aktteva Biopharma LLP, Wellona Pharma, Atom pharma, Sinoway Industrial Co. Ltd, Cerata Pharmaceuticals LLP
What Losartan Potassium Active Pharmaceutical Ingredient (API) Market Trends Are Gaining Traction Across Different Segments?
Leading businesses in the losartan potassium active pharmaceutical ingredient (API) market are concentrating on expanding therapeutic uses and improving patient compliance through the development of innovative products and securing needed approvals such as losartan potassium oral suspension. This is a liquid medication for those who find it difficult to ingest tablets. For example, in March 2025, US-based biopharmaceutical company Scienture Holdings Inc. attained approval from the Food and Drug Administration (FDA) for Arbli. Arbli is a readymade liquid solution for stroke risk reduction in hypertensive patients with left ventricular hypertrophy, hypertension, and type 2 diabetes patients with diabetic nephropathy. It allows for precise dosage without the need for compounding and comes in a 165 mL peppermint-flavored suspension (10 mg/mL), remaining viable for 18 months at room temperature.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/losartan-potassium-active-pharmaceutical-ingredient-api-global-market-report
What Are the Top Revenue-Generating Geographies in the Losartan Potassium Active Pharmaceutical Ingredient (API) Market?
North America was the largest region in the losartan potassium API market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the losartan potassium active pharmaceutical ingredient (API) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Losartan Potassium Active Pharmaceutical Ingredient (API) Market?
2. What is the CAGR expected in the Losartan Potassium Active Pharmaceutical Ingredient (API) Market?
3. What Are the Key Innovations Transforming the Losartan Potassium Active Pharmaceutical Ingredient (API) Industry?
4. Which Region Is Leading the Losartan Potassium Active Pharmaceutical Ingredient (API) Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Losartan Potassium Active Pharmaceutical Ingredient (API) Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities here
News-ID: 4061239 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
